Long-term efficacy and safety of renal denervation in the presence of antihypertensive drugs (SPYRAL HTN-ON MED): a randomised, sham-controlled trial
Felix Mahfoud(University of Basel), Michael Böhm(Saarland University), Pamela McKenna(Medtronic (United States)), Stuart Pocock(London School of Hygiene & Tropical Medicine), James W. Choi(Baylor Jack and Jane Hamilton Heart and Vascular Hospital), Sebastian Ewen(Schwarzwald-Baar Klinikum), Michael A. Weber(SUNY Downstate Health Sciences University), Antony Walton, Raymond R. Townsend(University of Pennsylvania), Roland E. Schmieder(Universitätsklinikum Erlangen), Cara East(Baylor Jack and Jane Hamilton Heart and Vascular Hospital), Kyriakos Dimitriadis(National and Kapodistrian University of Athens), Martin Fahy(Medtronic (United States)), Konstantinos Tsioufis(National and Kapodistrian University of Athens), David E. Kandzari(Piedmont Atlanta Hospital), Richard D’Souza(Royal Devon and Exeter Hospital), Ingrid Hopper(The Alfred Hospital), Sandeep Brar(Medtronic (United States)), Andrew Sharp(University Hospital of Wales), Kazuomi Kario(University of Pennsylvania)
Cited by 282
Related Papers
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
|European Heart Journal|2021|13.1k
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC
|European Heart Journal|2012|6.9k
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
|New England Journal of Medicine|2019|6.8k
Empagliflozin in Heart Failure with a Preserved Ejection Fraction
|New England Journal of Medicine|2021|4.6k